2013
DOI: 10.1242/dmm.013078
|View full text |Cite
|
Sign up to set email alerts
|

An insert-based enzymatic cell culture system to rapidly and reversibly induce hypoxia: investigations of hypoxia-induced cell damage, protein expression and phosphorylation in neuronal IMR-32 cells

Abstract: SUMMARYIschemia-reperfusion injury and tissue hypoxia are of high clinical relevance because they are associated with various pathophysiological conditions such as myocardial infarction and stroke. Nevertheless, the underlying mechanisms causing cell damage are still not fully understood, which is at least partially due to the lack of cell culture systems for the induction of rapid and transient hypoxic conditions. The aim of the study was to establish a model that is suitable for the investigation of cellular… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 18 publications
(24 citation statements)
references
References 53 publications
0
23
0
1
Order By: Relevance
“…This was most likely attributed to the accumulation of cytotoxic byproduct, namely gluconic acid and H 2 O 2 . This is not a unique problem to our system as other GOX/CAT-induced hypoxia culture systems (e.g., soluble or membrane-bound enzyme) also exhibited decreased cytocompatibility after 24 hours of culture (Askoxylakis et al, 2011;Huang et al, 2013;Zitta et al, 2012). One potential solution for this drawback is to replace the GOX-immobilized hydrogel and the CAT supplemented media frequently.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This was most likely attributed to the accumulation of cytotoxic byproduct, namely gluconic acid and H 2 O 2 . This is not a unique problem to our system as other GOX/CAT-induced hypoxia culture systems (e.g., soluble or membrane-bound enzyme) also exhibited decreased cytocompatibility after 24 hours of culture (Askoxylakis et al, 2011;Huang et al, 2013;Zitta et al, 2012). One potential solution for this drawback is to replace the GOX-immobilized hydrogel and the CAT supplemented media frequently.…”
Section: Discussionmentioning
confidence: 99%
“…This system has been used to induce hypoxia in solutions and in microfluidic devices (Askoxylakis et al, 2011;Baumann et al, 2008;Huang et al, 2013;Li et al, 2016;Millonig et al, 2009;Mueller et al, 2009;Rajan et al, 2013;Sobotta et al, 2013;Zitta et al, 2012). The use of GOX/CAT is beneficial in that the system provides a rapid onset of hypoxia (usually within a few minutes) (Askoxylakis et al, 2011;Baumann et al, 2008;Huang et al, 2013;Li et al, 2016;Millonig et al, 2009;Mueller et al, 2009;Rajan et al, 2013;Sobotta et al, 2013;Zitta et al, 2012). One drawback to any GOX system, however, is the production of hydrogen peroxide, a reactive oxygen species (ROS) (Fruehauf and Meyskens, 2007) whose accumulation would not only cause undesired cellular response but also inactivate both GOX and CAT (Hielscher and Gerecht, 2015;Pal et al, 2000;Trachootham et al, 2009;Tse and Gough, 1987).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, using this system pH and glucose concentration in the culture medium decrease, resembling well the in vivo situation of I/R. 18,19 Hypoxic conditions were verified by using a tissue oxygen pressure monitor (LICOX CMP Oxygen Catheter; Integra). Pretests considering the increase in ischaemia-inducible factors in monocytes and progression of cell damage during I/R were performed to evaluate the optimal duration of ischaemia (3 hours) and reperfusion (24 hours beginning of ischaemia, T(0) directly after ischaemia and T(24) the end of reperfusion ( Figure 1).…”
Section: Experimental Settingmentioning
confidence: 70%
“…Apart from these, there are many type of commercial hypoxia simulating devices that are available in the market (Catalog #27310; Z736848; X3CYTOCENTRIC; C21HYPOXIA). The available commercial hypoxia chambers are designed as per specific application and requirements (Hsu & Chen, 2013; Huang, Zitta, Bein, Steinfath, & Albrecht, 2013; Wang, Jin, & Zhong, 2014). Hsu and Chen developed a hypoxia chamber with a microprobe that continuously monitors the electrical and optical properties of neuronal cells for drug screening and/or fundamental research related to ischaemic condition (Hsu & Chen, 2013).…”
Section: Introductionmentioning
confidence: 99%